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INTRODUCTION
Urologic malignancies (UM) are encountered
worldwide with varying patterns and prevalence1. UM
are major causes of morbidity and mortality with a
significant effect on age-adjusted life years in afflicted
individuals2. Technological advancement in diagnostic
modalities, minimal access surgery and modern drugs
have changed the face of diagnosis and treatment of
UM2. Nigeria, the most populous black nation in the
world has witnessed an increasing burden of UM in
the past decade especially Prostate cancer (PCa)3, 4.
Reports from tertiary centres in different geo-political
zones of Nigeria have shown some epidemiological
peculiarities in the pattern of  UM with higher reports
of bladder cancer in the Northern part of Nigeria5.
In the oil-rich Southern Nigeria, certain genetic
predisposing factors and environmental exposure have
been alluded to in the aetio-pathogenesis of some
UM6, 7.
From previous studies, UM account for a significant
burden of cancer patients in Nigeria. Prostate  and
bladder cancer have been shown to be the commonest
malignancies across Nigeria in papers from South-
south and North-western Nigeria respectively5, 8. There
is however paucity of  information on the recent pattern
of UM in South-western Nigeria.
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Introduction: The last decade witnessed a remarkable rise in the
prevalence of several malignant diseases in Nigeria. Whether Urologic
malignancies (UM) have followed the same trend remains to be studied.
The pattern of  UM diagnosed in a Nigerian tertiary hospital is hereby
presented. Our aim was to determine the pattern and prevalence of
histologically diagnosed UM in Obafemi Awolowo University Teaching
Hospitals Complex. Ile-Ife, Nigeria.
Materials and Methods: A 10-year retrospective review of all patients
diagnosed with UM was carried out between January 2005 and December
2014. Data was obtained from the patients’ case files and the Ife-Ijesha
Cancer registry. Information obtained included demographic
characteristics, site of  origin and histology. Data was analysed with
Statistical package for Social sciences (SPSS) Version 20.
Results: A total of  4675 malignancies were histologically confirmed
during the study period. UM accounted for 420 (8.9%) of total
malignancies. Prostate cancer was the commonest UM with 315 (75%)
cases. Others include renal tumours 62(14.8%), bladder tumours 29
(6.9%), testicular tumours 13(3.1%) and scrotal tumour 1(0.2%). UM
were commoner in males (348, 88.8%) than females (47, 11.2%) and
accounted for 13.8% and 2.18% of all tumours in males and females
respectively.
Conclusion: This study revealed a rising prevalence of UM most
especially Prostate and Renal Cancers among other malignancies in
Ile-Ife.
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This study aims to analyse the pattern of GUM
diagnosed at the Ife-Ijesha cancer registry over a 10-
year period.
MATERIALS AND METHODS
A 10-year retrospective review of all patients with
histological diagnosis of GUM between January 2005
and December 2014 at Obafemi Awolowo University
Teaching Hospitals Complex, Ile-Ife was done. Data
was obtained from the patients case files and the Ife-
Ijesha Cancer registry. Information obtained include
demographic characteristics, site of origin and
histologic details. The diagnosis was based on the World
Health Organization’s classification of  varied urological
cancers. Data was analysed with Statistical package for
Social Sciences (SPSS) Version 20.
RESULTS
UM accounted for 8.9% (420 of 4675) of
malignancies diagnosed within the study period. Of
all malignancies diagnosed and registered in the cancer
registry, there was a marginal male predominance with
male cancers numbering 2517 (53.8%) and female
cancers 2158 (46.2%). Overall, UM made up 14.82%
of male malignancies and  2.18% of female
malignancies. UM were commoner in males 373
(88.8%) than females 47 (11.2%) with a male:female
ratio of 9 : 1. The mean age of patients with UM
were 53.5 years. Mean ages for different urologic
tumours are depicted on Table 1.
The primary organs affected were the Prostate
(315;75%), the kidney (62;14.8%), the bladder
(29;6.9%), the testis (13;3.1%) and the scrotum
(1;0.24%).
The peak age for prostate cancer was in the 7th decade
of  life with histology of  Adenocarcinoma accounting
for all. Renal Cell Carcinoma was the second
commonest malignancy and was seen more commonly
in females (37; 59.7%) than males (25; 41.3%) with the
clear cell variant making up greater than one third of
the patients. Bladder tumours ranked third and were
more commonly found in men (19;65.6%) than
women (10;34.4%) with transitional cell carcinoma
variant making up more than half  of  the cases. Other
histological details are as seen on Table 2. Testicular
tumours and a solitary case of scrotal squamous cell
Tumours Total (% of total
Malignancies)
% of Adult Urologic
Malignancies
Mean Age (years)
Prostate Cancer 315 (6.74) 75 69.80
Renal Cancer 62 (1.33) 14.76 41.70
Bladder Cancer 29 (0.62) 6.90 63.60
Testicular Cancer 13 (0.28) 3.10 30.60
Scrotal Cancer 1 (0.022) 0.24 62.00
Total 420 (8.98) 100
Table 1: Summary of  genito-urinary malignancies in Ile-Ife (From Ife-Ijesha Cancer Registry).
Figure 1 : Distribution of Genito-urinary tract malignancies in Ile-Ife between 2005 and 2014
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carcinoma accounted for the rest. No cases of renal
pelvis, ureteral, urethral or penile tumours were
managed during the study period.
DISCUSSION
This review shows that over the last decade, UM
accounted for 8.4% of all histologically diagnosed
malignancies in our immediate community. This
suggests that 1 in every 10 cases of  cancer is a UM.
This was similar to findings in Jos, Korle-Bu and
Zambia9-11. It was however less prevalent than in studies
from Kano and India2, 8. Compared to the year 2005,
the 60% rise in overall prevalence of UM from 2011-
2014 are mostly attributable to Prostate and Renal
Cancers. This could be attributed to more recent
community-based health education and screening
programs in Ile-Ife community associated with higher
number of  apparently healthy patients presenting for
routine prostate specific antigen checks, ultrasound
scans and prostate biopsies. There has also been a rise
in incidental diagnosis of renal tumours during routine
ultrasound scans in Ile-Ife in recent times12. Dauda and
his associates also corroborated a rise in the prevalence
of UM in North-eastern Nigeria13.
Historically, it was believed that PCa was relatively rare
among men of African descent14, our study contrarily
buttresses the high prevalence of PCa in our
environment accounting for 75% of all UM. There is
overwhelming evidence in literature that PCa is the
commonest UM3, 8, 9, 13, 15, 16. In Nigeria, PCa has surpassed
Hepatocellular carcinoma as the commonest malignancy
in men3. Adenocarcinoma was the dorminant
histological type of PCa in our study which is similar
to other local and international reports1, 8.
Findings of renal cell carcinoma (RCC) as the second
commonest urological cancer in this studyis contrary
to majority of studies from across Nigeria where
bladder tumour has since been reported as the second
commonest UM5, 8, 9, 13. Perhaps the relative rural
environment devoid of exposure to industrial
carcinogens as well as paucity of schistosoma endemic
streams may account for this peculiarity.
This study shows that the mean age for RCC was 41.7
years and it was found to be more common among
women with Male: Female ratio of  1: 1.5. The lower
mean age and increased prevalence among women
was a sharp contrast to a previous report from our
center where a mean age of 47.5 years and male:
female ratio of 13:517. In Nigeria, Tijani and Mbaeri et
al in Lagos and Nnewi respectively,also found a higher
incidence of RCC in females18, 19. Reasons for these
differences were attributed to the increased number
of women with incidentally discovered RCC during
routine ultrasound in pregnancy. The clear cell variant
was the commonest histological type in this study, this
was different from the papillary cell variant which was
reported by Ofuru and his assocites reported in Port-
Harcourt, Nigeria5.







































Scrotal Cancer Squamous Cell Carcinoma 1 (100)
Table 2: Histopathological breakdown of  GUM in Ile-Ife.
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Bladder tumours were the third commonest urological
malignancy in our study with male:female ratio of 2:1.
This ratio was similar to findings by Forae in Benin
and Takure et al in Ibadan, both in Nigeria20, 21 however
males were observed to have a much higher ratio of
5.6: 1 in Port-Harcourt5. Urothelial tumour (transitional
cell carcinoma) was the commonest histological type
found in our report. This is in keeping with the global
trends2. Even in the Northern part of Nigeria, there
seems to be a change in the trend ofbladder tumours
with higher incidence of urothelial tumours compared
to Squamous cell Carcinoma as was seen two decades
ago due to endemicity of schistosomiasis in these parts9,
22. We generally believe that the semi-urban setting of
our immediate environment with a paucity of chemical
industries and schistosoma infested streams may have
accounted for a lower prevalence of  bladder tumours.
Testicular tumours were found to be rare with no
change in prevalence over the 10-year period under
review and it accounted for 3.1% of all urologic
malignancies. This is slightly higher than 0.5-2% which
is quoted worldwide as incidence of testicular cancer8,
23, 24.
Germ cell tumours (GCT) accounted for 38.4% and
were the commonest histologic sub-type in this study.
This was similar to findings from previous local and
international studies23, 25. Paratesticular tumours
especially rhabdomyosarcoma still appear to be
relatively common in our community accounting for
about half  of  the patients. This corroborates the report
from Salako et al, in 2010 in our hospital who found
paratesticular tumours accounting for 38.5% of
testicular tumours with majority being rhabdomyo-
sarcoma26. There was solitary case of scrotal squamous
cell carcinoma which is a rare disease27.
CONCLUSION
There is an obvious increase in the prevalence of UM
in Ile-Ife, mostly accounted for by Prostate and Renal
Cancers. This is possibly attributable to increased health
education and awareness among indigenes. Renal cancer
seems to have replaced bladder cancer as the second
commonest UM in Nigeria. There is need for a larger
scale National study in order to identify the true pattern
of urologic malignancies in Nigeria.
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